BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies.

Corrado Zengarini Martina Mussi Giulia Veronesi Aurora Maria Alessandrini Martina Lambertini Emi Dika

Published in: Clinical and experimental dermatology (2022)

Despite the small size of this study, the results show similar clinical and dermoscopic characteristics between V600E and V600K mutations, but compared with BRAF V600E MMs, BRAF V600K MMs seem to be less responsive to therapy and have a worse prognosis.

Keyphrases

metastatic colorectal cancer
wild type
stem cells
drug delivery
bone marrow